Christopher Nolan

Christopher Nolan is a seasoned biopharma professional with a solid background encompassing over 10 years of experience in scientific, clinical, and commercial functions.

During a tenure at Merck, Christopher honed his expertise in various operational and cross-functional capacities within the research and development sector, empowering him with a robust skill set.

With a track record of over 50 consulting projects with prominent life science firms, Christopher has cultivated profound analytical and commercial proficiencies.

His therapeutic focus lies in Oncology, Infectious Diseases, Rare and Genetically Defined Diseases, underpinning his proficiency in these critical areas of healthcare.

Christopher's areas of concentration include Search and Evaluation, Due Diligence, Valuation, New Product Planning, Corporate Strategy, Market Development, and Launch Excellence, reflecting his diverse skill set and strategic mindset.

He pursued a Master's in Management and Engineering at Duke University, complementing his Bachelor of Science in Biomedical Engineering from the University of Rochester.

With a rich professional history, Christopher has held key positions such as Principal at Mddetails, Associate Director at Navigant, Managing Consultant at Leerink Partners LLC, as well as roles at Merck as a Project Scientist and Analyst.